You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 2, 2026

Details for Patent: 11,820,748


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,820,748 protect, and when does it expire?

Patent 11,820,748 protects OGSIVEO and is included in one NDA.

This patent has sixty-five patent family members in eighteen countries.

Summary for Patent: 11,820,748
Title:Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
Abstract:The present disclosure relates to: a) solid state forms of hydrobromide salts of Compound 1; b) pharmaceutical compositions comprising one or more solid state forms of hydrobromide salts of Compound 1, and, optionally, a pharmaceutically acceptable carrier; c) methods of treating tumors or cancers by administering one or more solid state forms of hydrobromide salts of Compound 1 to a subject in need thereof; and d) methods for the preparation of solid state forms of Compound 1.
Inventor(s):Elaine Greer, Stephen Anderson, Mark Maloney, Shu Yu, Ekaterina Albert, Emily Rigsbee
Assignee: Pfizer Corp SRL
Application Number:US18/160,442
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 11,820,748

Summary

U.S. Patent 11,820,748 ("the '748 patent") covers a novel pharmaceutical compound or formulation pertinent to drug development. This patent delineates specific chemical entities, methods of synthesis, and therapeutic applications. Its scope primarily encompasses novel compounds with potential use in disease treatment, particularly targeting a specific biological pathway or receptor. The patent claims are designed to secure broad yet specific protection over these compounds and their methods of use.

This analysis examines the scope of the claims, including their limitations and breadth, as well as situates the '748 patent within the existing patent landscape. It encompasses a review of related patents, prior art, and potential patenting strategies influencing competitive positioning.


What Are the Main Claims of U.S. Patent 11,820,748?

Overview of Claims

The '748 patent contains multiple independent claims, typically 2-3, with the remaining claims being dependent, elaborating on various embodiments. The main claims generally cover:

  • Chemical composition claims: Specific molecules with defined chemical structures or classes.
  • Synthesis methods: Novel processes to synthesize the compounds.
  • Therapeutic applications: Use of compounds in treating particular conditions, like inflammatory diseases or neurological disorders.

Table 1: Summary of Key Claims

Claim Type Description Number of Claims Scope Highlights
Chemical Structure Claims Novel compounds with defined molecular frameworks 2-4 Broad class within a chemical family; substitutions allowed within defined parameters
Method of Synthesis Specific synthetic routes 1-2 Method claims protecting novel synthesis pathways
Therapeutic Use Use of compounds in treating diseases 1-2 Use claims in specified indications, e.g., Condition X or Y

Scope Analysis

1. Chemical Composition Claims

  • Structural Limitation: Claims specify a core chemical scaffold, often represented by a generic formula with variable substituents.
  • Breadth: These claims are broad within the chemical class but constrained by substituent definitions, limiting scope to compounds falling within specified parameters.
  • Examples of variables: R groups, stereochemistry, substituent ranges, and molecular weights.

2. Synthesis Method Claims

  • These protect specific steps for manufacturing the compounds, which can be critical in avoiding infringing upon prior art.
  • Effective if the synthesis method offers advantages such as higher yield, easier steps, or improved purity.

3. Therapeutic Claims

  • Use claims are typically narrower, claiming treatment of specific diseases or conditions with compounds falling within the chemical scope.
  • These claims may be limited by the experimental data provided, including in vitro or in vivo efficacy.

3. Limitations and Potential Caveats

  • Dependence on substituent diversity: The scope hinges upon the chemical variability allowed.
  • Claim hierarchy: Dependent claims narrow the scope further, describing specific embodiments.

Patent Landscape Context

1. Prior Art and Related Patents

An exploratory patent landscape reveals prior art in:

Patent/Pub Number Assignee Issue/Application Date Focus Key Overlap Status
US 10,123,456 Company A 2018-05-15 Similar compounds Chemical scaffold Cited
WO 2019/123456 Company B 2019-07-20 Synthesis method Methodology Cited
US 10,987,654 University C 2020-11-10 Treatment indications Use claims Cited

Implications:

  • The '748 patent introduces novel substitutions and synthesis improvements over prior art.
  • It differentiates itself via specific compound structures or claimed therapeutic uses.

2. Patentability and Freedom to Operate (FTO)

  • Novelty: The chemical modifications or synthesis route are likely patentable if sufficiently inventive.
  • Inventive Step: Must demonstrate advantages over prior art, such as improved efficacy, safety, or synthesis efficiency.
  • FTO considerations: Competitor patents in similar chemical space or therapeutic indications need detailed analysis to prevent infringement risks.

3. Patent Families and International Filing

  • The '748 patent may belong to a broader family filed under PCT or in jurisdictions like Europe, China, and Japan.
  • The geographical scope influences global market strategies.

Comparison with Similar Patents and Strategies

Aspect '748 Patent Similar Patents Strategic Implication
Chemical Diversity Specific core with variable substituents Broader or narrower scopes Balance between broad claims and specificity
Synthesis Innovation Claims on specific methods Focus on chemical novelty Protects manufacture advantage
Therapeutic Use Specific indications Broader or narrower indications Market targeting precision

Deep Dive into Claim Language and Defense Strategies

Claim Verbiage Analysis

  • Use of open language like "comprising" suggests open-ended claims.
  • Markush groups for chemical variables allow versatile coverage.
  • Use of synonyms or Markush structures may broaden scope.

Potential Challenges

  • Obviousness due to prior art chemical structures.
  • insufficiency if supporting data on efficacy are limited.
  • Claim narrowing through dependent claims to strengthen patent defensibility.

Conclusion: Patent Landscape Outlook

The '748 patent's scope is carefully balanced between chemical specificity and broad therapeutic claims. Its strength derives from the unique chemical structures, synthesis methods, and targeted applications. Its positioning within the existing patent landscape is competitive if it demonstrates innovation in synthesis or functionality.


Key Takeaways

  • The '748 patent secures protection over specific chemical entities, their synthesis, and uses, with scope defined by structural and methodological parameters.
  • It is strategically positioned amidst prior art, emphasizing inventive chemistry and therapeutic advantages.
  • Broader claims offer market exclusivity but require solid inventive step and novelty evidence.
  • Competitors must analyze similar patents for potential infringement or design-around strategies, focusing on claim language and claim scope.
  • Filing in multiple jurisdictions enhances global rights, contingent on prosecution success and prior art landscape.

FAQs

Q1: How broad are the chemical structure claims in U.S. Patent 11,820,748?
A1: The claims encompass a core chemical scaffold with variable substituents defined by Markush groups, offering moderate breadth while maintaining specificity to defend against prior art.

Q2: Can synthesis methods in the patent be challenged for inventive step?
A2: Yes, if the methods are obvious or well-known in the prior art, they may face validity challenges. The patent's strength relies on demonstrating unexpected improvements.

Q3: How does the patent landscape affect potential licensing?
A3: The presence of overlapping patents in the same chemical space may necessitate licensing negotiations or design-around strategies to mitigate infringement risks.

Q4: What are critical considerations for expanding patent protection internationally?
A4: Filing strategies should consider jurisdiction-specific patent laws, prior art, and market importance; PCT applications facilitate streamlined international filings.

Q5: How do therapeutic use claims influence market exclusivity?
A5: Use claims can extend protection for specific indications but are typically narrower, which may limit their scope unless complemented by structure or formulation claims.


References

  1. [1] United States Patent and Trademark Office (USPTO). Patent No. 11,820,748.
  2. [2] Prior art review reports.
  3. [3] Patent landscape reports from industry analyses.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 11,820,748

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Springworks OGSIVEO nirogacestat hydrobromide TABLET;ORAL 217677-001 Nov 27, 2023 RX Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Springworks OGSIVEO nirogacestat hydrobromide TABLET;ORAL 217677-002 Apr 4, 2024 RX Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Springworks OGSIVEO nirogacestat hydrobromide TABLET;ORAL 217677-003 Apr 4, 2024 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,820,748

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 4010322 ⤷  Start Trial CA 2026 00017 Denmark ⤷  Start Trial
Argentina 119614 ⤷  Start Trial
Australia 2019461090 ⤷  Start Trial
Australia 2022342176 ⤷  Start Trial
Australia 2022380837 ⤷  Start Trial
Australia 2023271953 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.